6American Diabetes Association. The pharmacological treatment of hyperglycemia in NIDDM. Diabetes Care, 1995,18 ( 11 ): 1510-1518.
7Levy J, Atkinson AB, Bell PM, et al. Beta-cell deterioration determines the onset and rate of progression of secondary dietary failure in type 2 diabetes mellitus: the 10-year follow-up of the Belfast Diet Study. Diabet Med, 1998,15 (4) :290-296.
8Haffner SM, Miettinen H, Stem MP. The homeostasis model in the San Antonio heart study. Diabetes Care, 1997,20(7) :1087-1092.
9Sa JR, Silva RC, Nasri F,et al. Non-obese adult onset diabetes with oral hypoglycemic agent failure:islet cell auto antibodies or reversible beta cell refractoriness. Braz J Med Biol Res, 2003,36 ( 10 ):1301-1309.
10Kosaka K, Kobayashi T,Nakanishi K, et al. Small doses of subcutaneous insulin as a strategy for preventing slowly progressive beta-cell failure in islet patients with clinical features of NIDDM. Diabetes,1996,45 ( 5 ) :622-626.
